QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.104.002840v1 33/4/484    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yu, L. J. Articles by Hop, C. E. C. A. Search for Related Content PubMed PubMed Citation Articles by Yu, L. J. Articles by Hop, C. E. C. A.

SHORT COMMUNICATION

IDENTIFICATION OF A NOVEL GLUTATHIONE ADDUCT OF DICLOFENAC, 4'-HYDROXY-2'-GLUTATHION-DESCHLORO-DICLOFENAC, UPON INCUBATION WITH HUMAN LIVER MICROSOMES

Department of Pharmacokinetics, Pharmacodynamics, and Metabolism (L.J.Y., Y.C., C.E.C.A.H.), Department of Cardiovascular and Metabolic Diseases (M.P.D.), and Department of Structural Chemistry and Computational Chemistry (T.N.O.), Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut

Clinical use of the nonsteroidal anti-inflammatory drug diclofenac (DF) is associated with an incidence of idiosyncratic hepatoxicity. The formation of reactive metabolites of DF in vivo has been proposed to be responsible for such toxicity. One type of reactive metabolite, a benzoquinone imine of DF formed through oxidation by cytochromes P450, can be trapped by glutathione in vitro in liver microsomes to form glutathione (GS) adducts. Three GS adducts from DF were reported in the literature, namely, 5-hydroxy (OH)-4-glutathione-DF, 4'-OH-3'-glutathione-DF and 5-OH-6-glutathione-DF, and they all have the same molecular weight of 616. Recently, we developed a sensitive and high throughput method for the detection of GS adducts from liver microsome incubation. This method uses a constant neutral loss scan of m/z 129, a "structure-characteristic" fragment for GS adduct, on an automated chip-based nanoelectrospray (Advion NanoMate 100) attached to a tandem mass spectrometer (Sciex API 3000). The analysis of GS adducts from human liver microsome incubation with DF by the NanoMate 100-API 3000 method unambiguously revealed a new adduct ion with m/z 583 (MH⁺), in addition to the known adduct peak with m/z 617 (MH⁺). This new adduct was further confirmed to be 4'-OH-2'-glutathion-deschloro-diclofenac by liquid chromatography (LC) tandem mass spectrometry (MS), LC/MS-NMR, and comparison to a synthetic standard.

This article has been cited by other articles:

				B. Wen, L. Ma, A. D. Rodrigues, and M. Zhu Detection of Novel Reactive Metabolites of Trazodone: Evidence for CYP2D6-Mediated Bioactivation of m-Chlorophenylpiperazine Drug Metab. Dispos., May 1, 2008; 36(5): 841 - 850. [Abstract] [Full Text] [PDF]

				Y. Li, J. G. Slatter, Z. Zhang, Y. Li, G. A. Doss, M. P. Braun, R. A. Stearns, D. C. Dean, T. A. Baillie, and W. Tang In Vitro Metabolic Activation of Lumiracoxib in Rat and Human Liver Preparations Drug Metab. Dispos., February 1, 2008; 36(2): 469 - 473. [Abstract] [Full Text] [PDF]

				Q. Chen, G. A. Doss, E. C. Tung, W. Liu, Y. S. Tang, M. P. Braun, V. Didolkar, J. R. Strauss, R. W. Wang, R. A. Stearns, et al. EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS Drug Metab. Dispos., January 1, 2006; 34(1): 145 - 151. [Abstract] [Full Text] [PDF]